Related Experiment Video

Updated: Aug 6, 2026

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays
11:17

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays

Published on: June 13, 2019

[Inhibitory effect on proliferation of KG1a cell line by methyltransferase inhibitors]

Hua Chen1, Shu-Lan Wu, Qiang Zhu

  • 1Department of Hematology, The First Hospital of Peking University, Beijing 100034, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi
|January 7, 2003
PubMed

Insights

This study explored DNA methylation inhibitors to re-express the p15 suppressor gene in leukemia. Results show these agents inhibit leukemia cell growth, induce apoptosis, and partially restore p15 protein, suggesting a new therapeutic strategy.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Leukemia treatment can be advanced by targeting gene expression.
  • DNA hypermethylation suppresses tumor suppressor genes like p15.
  • Re-expressing p15 may offer a novel therapeutic avenue for leukemia.

Purpose of the Study:

  • To investigate DNA methylation intervention for leukemia therapy.
  • To assess the efficacy of 5-Aza-2'-deoxycytidine (5-Aza-CdR) and a cell differentiation agent (CDAII) in a myelogenous leukemia cell line.
  • To determine if these agents can re-express the silenced p15 suppressor gene.

Main Methods:

  • Treatment of KG1a myelogenous leukemia cells with 5-Aza-CdR and CDAII.
  • Analysis of cell proliferation, apoptosis, and cell cycle arrest via flow cytometry.
  • Assessment of DNA methylation, DNA methyltransferase activity, and p15 protein re-expression using methylation-specific PCR (MSP) and other molecular techniques.

Main Results:

  • Both 5-Aza-CdR and CDAII demonstrated concentration- and time-dependent inhibition of leukemia cell proliferation.
  • Agents induced apoptosis and cell differentiation, with specific cell cycle arrests (G2 for 5-Aza-CdR, G0/G1 for CDAII).
  • Reduced DNA methyltransferase activity and genomic DNA methylation levels were observed, alongside partial re-expression of p15 protein.

Conclusions:

  • Intervening in DNA methylation via methyltransferase inhibitors is a potential therapeutic strategy for leukemia.
  • The re-expression of the p15 suppressor gene is achievable through this approach.
  • Further research into the mechanisms of this novel leukemia treatment strategy is warranted.

More Related Videos

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells08:11

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

Published on: August 7, 2021

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...